Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma. [electronic resource]
Producer: 20100310Description: 263-72 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Lymphoma, B-Cell -- mortality
- Male
- Middle Aged
- Remission Induction
- Rituximab
- Secondary Prevention
- Survival Analysis
- Transplantation, Autologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.